Catalyst Pharmaceuticals, Inc.
CPRXDelisted Jul 15, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001369568
Catalyst Pharmaceuticals, Inc. was delisted on Jul 15, 2026; its insiders filed their last Form 4 on Jul 17, 2026; 395 institutions reported holding it in 13F filings for Q2 2026, worth $3.39B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q4 2024
Institutional positions in Catalyst Pharmaceuticals, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 336
- +23 vs. Q3 2024
- Shares held
- 97.6M
- +2.43M (+2.6%) vs. Q3 2024
- Total value
- $2.04B
- +$145.4M (+7.7%) vs. Q3 2024
- New holders
- 59
- 139 more added
- Sold out
- 36
- 93 more reduced
3 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CPRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 395 | $3.39B |
| Q1 2026 | 382 | $2.59B |
| Q4 2025 | 375 | $2.43B |
| Q3 2025 | 360 | $2.04B |
| Q2 2025 | 365 | $2.20B |
| Q1 2025 | 370 | $2.37B |
| Q4 2024 | 336 | $2.04B |
| Q3 2024 | 316 | $1.90B |
| Q2 2024 | 271 | $1.50B |
| Q1 2024 | 268 | $1.53B |
| Q4 2023 | 259 | $1.42B |
| Q3 2023 | 256 | $948.8M |
| Q2 2023 | 248 | $1.11B |
| Q1 2023 | 260 | $1.47B |
| Q4 2022 | 257 | $1.56B |
| Q3 2022 | 229 | $1.09B |
| Q2 2022 | 190 | $531.7M |
| Q1 2022 | 186 | $585.5M |
| Q4 2021 | 164 | $446.7M |
| Q3 2021 | 144 | $345.1M |
| Q2 2021 | 139 | $376.6M |
| Q1 2021 | 133 | $312.0M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Catalyst Pharmaceuticals, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Jupiter Asset Management Ltd | 481,987 | $10.1M | 0.10% | −217,957−31.1% | Reduced |
| Standard Life Aberdeen plc | 484,666 | $10.1M | 0.02% | +484,666 | New |
| Millennium Management LLC | 520,778 | $10.9M | 0.01% | −38,989−7.0% | Reduced |
| Voloridge Investment Management, LLC | 531,836 | $11.1M | 0.04% | −235,393−30.7% | Reduced |
| Prudential Financial Inc | 553,424 | $11.5M | 0.02% | +128,525+30.2% | Added |
| Principal Financial Group Inc | 600,488 | $12.5M | 0.01% | +24,535+4.3% | Added |
| Qube Research & Technologies Ltd | 659,252 | $13.8M | 0.02% | −7,988−1.2% | Reduced |
| Macquarie Group Ltd | 682,652 | $14.2M | 0.02% | +682,652 | New |
| Arrowstreet Capital, Limited Partnership | 698,152 | $14.6M | 0.01% | +396,506+131.4% | Added |
| UBS Group AG | 722,858 | $15.1M | 0.00% | +510,013+239.6% | Added |
| Bank of New York Mellon Corp | 723,545 | $15.1M | 0.00% | +9,194+1.3% | Added |
| JPMorgan Chase & Co | 736,197 | $15.4M | 0.00% | +327,936+80.3% | Added |
| Skandinaviska Enskilda Banken AB (publ) | 731,900 | $15.4M | 0.07% | +312,000+74.3% | Added |
| Mesirow Institutional Investment Management, Inc. | 742,295 | $15.5M | 1.19% | −58,503−7.3% | Reduced |
| LSV Asset Management | 777,124 | $16.2M | 0.04% | −174,200−18.3% | Reduced |
| Invesco Ltd. | 846,851 | $17.7M | 0.00% | −92,675−9.9% | Reduced |
| Jacobs Levy Equity Management, Inc | 912,999 | $19.1M | 0.07% | −144,391−13.7% | Reduced |
| Kennedy Capital Management, Inc. | 1,017,666 | $21.2M | 0.47% | −23,750−2.3% | Reduced |
| Price T Rowe Associates Inc | 1,215,438 | $25.4M | 0.00% | −18,945−1.5% | Reduced |
| Charles Schwab Investment Management Inc | 1,246,925 | $26.0M | 0.00% | +79,182+6.8% | Added |
| Nuveen Asset Management, LLC | 1,304,391 | $27.2M | 0.01% | +165,249+14.5% | Added |
| Boston Partners | 1,291,868 | $27.3M | 0.03% | +16,601+1.3% | Added |
| Northern Trust Corp | 1,503,566 | $31.4M | 0.00% | +119,766+8.7% | Added |
| Bank of America Corp | 1,568,791 | $32.7M | 0.00% | +913,843+139.5% | Added |
| Royce & Associates LP | 1,864,351 | $38.9M | 0.36% | −156,754−7.8% | Reduced |
| Morgan Stanley | 2,088,050 | $43.6M | 0.00% | +264,776+14.5% | Added |
| First Trust Advisors LP | 2,233,834 | $46.6M | 0.04% | −195,139−8.0% | Reduced |
| Geode Capital Management, LLC | 2,665,472 | $55.6M | 0.00% | +1,0480.0% | Added |
| Renaissance Technologies LLC | 2,706,116 | $56.5M | 0.08% | +180,100+7.1% | Added |
| Goldman Sachs Group Inc | 2,802,373 | $58.5M | 0.01% | +1,330,120+90.3% | Added |
| Pacer Advisors, Inc. | 2,955,508 | $61.7M | 0.13% | +151,495+5.4% | Added |
| Dimensional Fund Advisors LP | 3,013,032 | $62.9M | 0.02% | −5,757−0.2% | Reduced |
| Deerfield Management Company, L.P. (Series C) | 3,133,011 | $65.4M | 1.24% | −3,096,623−49.7% | Reduced |
| State Street Corp | 5,796,560 | $121.0M | 0.00% | +111,230+2.0% | Added |
| Vanguard Group Inc | 8,431,094 | $176.0M | 0.00% | +390,116+4.9% | Added |
| BlackRock, Inc. | 19,425,129 | $405.4M | 0.01% | +407,638+2.1% | Added |
| Brandywine Global Investment Management, LLC | 0 | $0 | 0.00% | −392,118−100.0% | Sold out |
| 1832 Asset Management L.P. | 0 | $0 | 0.00% | −225,800−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −159,305−100.0% | Sold out |
| Opaleye Management Inc. | 0 | $0 | 0.00% | −112,500−100.0% | Sold out |
| Livforsakringsbolaget Skandia, Omsesidigt | 0 | $0 | 0.00% | −110,900−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −105,743−100.0% | Sold out |
| Bridger Management, LLC | 0 | $0 | 0.00% | −90,651−100.0% | Sold out |
| TD Asset Management Inc | 0 | $0 | 0.00% | −71,800−100.0% | Sold out |
| Friedenthal Financial | 0 | $0 | 0.00% | −37,139−100.0% | Sold out |
| Brookstone Capital Management | 0 | $0 | 0.00% | −33,506−100.0% | Sold out |
| FORA Capital, LLC | 0 | $0 | 0.00% | −25,933−100.0% | Sold out |
| Guggenheim Capital LLC | 0 | $0 | 0.00% | −24,760−100.0% | Sold out |
| Caxton Associates LP | 0 | $0 | 0.00% | −20,762−100.0% | Sold out |
| Simplicity Wealth,LLC | 0 | $0 | 0.00% | −17,477−100.0% | Sold out |
| Scientech Research LLC | 0 | $0 | 0.00% | −16,780−100.0% | Sold out |
| AlphaMark Advisors, LLC | 0 | $0 | 0.00% | −16,486−100.0% | Sold out |
| Everence Capital Management Inc | 0 | $0 | 0.00% | −15,260−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −14,741−100.0% | Sold out |
| Paloma Partners Management Co | 0 | $0 | 0.00% | −14,730−100.0% | Sold out |
| Brinker Capital Investments, LLC | 0 | $0 | 0.00% | −13,212−100.0% | Sold out |
| Orion Portfolio Solutions, LLC | 0 | $0 | 0.00% | −13,212−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −12,325−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −10,892−100.0% | Sold out |
| ISAM Funds (UK) Ltd | 0 | $0 | 0.00% | −10,869−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −10,057−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −8,500−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −8,108−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −2,986−100.0% | Sold out |
| nVerses Capital, LLC | 0 | $0 | 0.00% | −2,500−100.0% | Sold out |
| Voisard Asset Management Group, Inc. | 0 | $0 | 0.00% | −970−100.0% | Sold out |
| Capital Performance Advisors LLP | 0 | $0 | 0.00% | −646−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −271−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −133−100.0% | Sold out |
| Frazier Financial Advisors, LLC | 0 | $0 | 0.00% | −82−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −35−100.0% | Sold out |
| Mendota Financial Group, LLC | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Raymond James Financial Services Advisors, Inc. | – | – | – | – | Not filed |
| Raymond James & Associates | – | – | – | – | Not filed |
| Planning Capital Management Corp | – | – | – | – | Not filed |